表紙
市場調查報告書

微射流的全球市場:各材料、零組件 (微射流晶片/幫浦/針頭)、用途的預測

Microfluidics Market - By Material (Ceramics, Polymers), By Components (Microfluidic Chips, Pumps, Needles), By Application (In-Vitro Diagnostics, Pharmaceutical Research, Drug Delivery) - World Forecasts to 2022

出版商 RNCOS E-Services Pvt. Ltd. 商品編碼 486151
出版日期 內容資訊 英文 90 Pages
訂單完成後即時交付
價格
微射流的全球市場:各材料、零組件 (微射流晶片/幫浦/針頭)、用途的預測 Microfluidics Market - By Material (Ceramics, Polymers), By Components (Microfluidic Chips, Pumps, Needles), By Application (In-Vitro Diagnostics, Pharmaceutical Research, Drug Delivery) - World Forecasts to 2022
出版日期: 2019年05月01日內容資訊: 英文 90 Pages
簡介

本報告提供全球微射流市場相關分析,技術、產品概要,及市場基本結構、最新形勢,主要的推動及阻礙市場要素,市場規模趨勢預測 (總計6年份),各材料、各零件、各用途、各地區的詳細趨勢,今後的資本交易、市場成長機會,主要企業簡介等調查。

第1章 分析師的見解

第2章 分析方法

第3章 微射流 (微小液體技術):概要

第4章 微射流市場概要

  • 微射流市場
  • 醫療用微射流市場

第5章 市場推動因素與課題

  • 推動市場要素
  • 課題

第6章 市場區隔

  • 各材料
    • 陶瓷製
    • 聚合物製
    • 其他
  • 各零件
    • 微射流用晶片市場
    • 微射流用幫浦市場
    • 微射流用針頭市場
    • 其他
  • 各用途
    • 體外 (IV) 診斷
    • 藥物/生命科學研究
    • 藥物遞送 (藥物輸送)
    • 其他
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 其他的國家 (RoW)

第7章 法規方案

  • 北美 (美國等)
  • 歐洲
  • 亞太地區 (印度,中國)

第8章 市場趨勢和動靜

  • 微射流研究的津貼交付的發表
  • 企業合併、收購 (M&A)

第9章 企業的評估

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Microfluidics is the science and technology discipline of controlling fluids, usually in the range of microliters to picolitres, in networks of channels with lowest dimensions. The report "Microfluidics Market - By Material (Ceramics, Polymers), By Components (Microfluidic Chips, Pumps, Needles), By Application (In-Vitro Diagnostics, Pharmaceutical Research, Drug Delivery) - World Forecasts to 2022" studies the market for the application of microfluidics in pharmaceutical, in-vitro diagnostics, and drug delivery devices. The market is anticipated to grow at a robust CAGR during the forecasted period, i.e. 2017-2022. This growth is likely to be driven by the rising demand for point-of-care devices, quick return on investments provided by microfluidics devices resulting in cost reductions, and miniaturization of microfluidic chips.

On the contrary, manufacturing difficulties and high capital investment for lab-on-chip devices are two of the major challenges faced by this sector. Other major factors such as tough incorporation of emerging microfluidic technologies into existing workflows, and complex and time consuming regulatory standards are hampering the growth of microfluidics market.

According to analysis, the market for microfluidic devices all over the world was worth US$ 3.6 Billion in 2017, and is poised for a double digit growth during the forecasted period (2017-2022). The new report also focuses on microfluidics market by material, such as ceramics, polymers, glass, and silicon; by components, such as microfluidic chips, pumps, and needles; by application, and territory. The In-Vitro diagnostics segment commands the largest share of the global microfluidics applications market. The large share of this segment is attributed to the increasing adoption of microfluidics for Point-of-Care & Clinical and Veterinary diagnostics application by major diagnostic companies, such as Roche, Becton Dickinson and Company, Abbott, and Cepheid amongst others. Similarly, in microfluidics by components segment, microfluidic chips accounted for the largest share. This large share is attributed to increasing usage of these chips in IVD application.

Based on material, in 2017, ceramics contributed the major share in microfluidics market. This high share is attributed to high chemical resistivity, versatility, and strength offered by ceramics in manufacturing of microfluidics devices.

Asia Pacific is poised to witness a lucrative growth in the coming years. This is attributed to the increasing mergers and acquisitions, and technological advancements in emerging countries. However, North America accounted for the largest share in 2017. The increasing adoption of microfluidics technology and the incessant launches of new products in the North American region are driving the market growth.

In addition, this study also covers latest trends and developments capturing the market since last few years. The report also includes the regulatory scenario in various countries across the globe.

The key vendors dominating the market space are Fluidigm Corp., Roche, Agilent Technologies Inc., Illumina, Inc., Shimadzu, Abbott, etc. Finally, the report covers strengths and weaknesses, and recent developments on the competitive front. Thus, it provides a comprehensive analysis of the microfluidics technology, which will enable investors and debut makers to design relevant business strategies to target the billion dollar market.

1. Analyst View

2. Research Methodology

3. Microfluidics - An Introduction

4. Microfluidics Market Overview

  • 4.1 Microfluidics Market
  • 4.2 Healthcare Microfluidics Market

5. Drivers & Challenges

  • 5.1 Drivers
    • 5.1.1 Rising Incidence of Chronic Diseases
    • 5.1.2 Increasing Demand of Point of Care Diagnostics
    • 5.1.3 Rising Application in Life Sciences Research
    • 5.1.4 Benefits of Miniaturization of Chip
  • 5.2 Challenges
    • 5.2.1 Manufacturing Difficulties & High Cost of Lab-on Chips Instruments
    • 5.2.2 Ambiguous Regulatory Framework
    • 5.2.3 Lack of Awareness in Emerging Markets

6. Market Segmentation

  • 6.1 By Material
    • 6.1.1 Ceramics
    • 6.1.2 Polymers
    • 6.1.3 Others
  • 6.2 By Components
    • 6.2.1 Microfluidics Chips Based Microfluidic Devices
    • 6.2.2 Microfluidics Pumps Based Microfluidic Devices
    • 6.2.3 Microfluidics Needles Based Microfluidic Devices
    • 6.2.4 Others
  • 6.3 By Applications
    • 6.3.1 In-Vitro Diagnostics
    • 6.3.2 Pharmaceutical & Life Sciences Research
    • 6.3.3 Drug Delivery
    • 6.3.4 Others
  • 6.4 By Geography
    • 6.4.1 North America
    • 6.4.2 Europe
    • 6.4.3 Asia Pacific
    • 6.4.4 Rest of World

7. Regulatory Scenario

  • 7.1 US
  • 7.2 Europe
  • 7.3 Asia-Pacific
    • 7.3.1 India
    • 7.3.2 China

8. Trends & Developments

  • 8.1 Grants Announced for Microfluidics Research
  • 8.2 Mergers & Acquisitions

9. Competitive Assessment

  • 9.1 Fluidigm Corporation
  • 9.2 F. Hoffmann-La Roche Ltd.
  • 9.3 Bio-Rad Laboratories, Inc.
  • 9.4 Thermo Fisher Scientific, Inc.
  • 9.5 Agilent Technologies, Inc.
  • 9.6 Perkin Elmer, Inc.
  • 9.7 Illumina, Inc.
  • 9.8 Shimadzu Corporation
  • 9.9 Danaher Corporation
  • 9.10 Abbott

List of Figures:

  • Figure 4-1: Global - Microfluidics Market (Billion US$), 2017-2022
  • Figure 4-2: Share of Healthcare in Global Microfluidics Market (%), 2017 & 2022
  • Figure 4-3: Global - Healthcare Microfluidics Market (Billion US$), 2017-2022
  • Figure 6-1: Global - Microfluidics Market by Material (%), 2017
  • Figure 6-2: Global - Microfluidics Market for Ceramics (Billion US$), 2017-2022
  • Figure 6-3: Global - Microfluidics Market for Polymers (Billion US$), 2017-2022
  • Figure 6-4: Global - Microfluidics Market for Others (Billion US$), 2017-2022
  • Figure 6-5: Global- Microfluidics Market by Components (%), 2017
  • Figure 6-6: Global - Microfluidics Chip Based Microfluidics Market (Billion US$), 2017-2022
  • Figure 6-7: Global - Microfluidics Pumps Based Microfluidics Market (Billion US$), 2017-2022
  • Figure 6-8: Global - Microfluidics Needles Based Microfluidics Market (Billion US$), 2017-2022
  • Figure 6-9: Global - Other Microfluidic Components Market (Billion US$), 2017-2022
  • Figure 6-10: Global- Microfluidics Market by Applications (%), 2017
  • Figure 6-11: Global - Microfluidics Market for In-Vitro Diagnostics (Billion US$), 2017-2022
  • Figure 6-12: Global - Microfluidics Market for Pharmaceutical & Life Sciences Research (Billion US$), 2017-2022
  • Figure 6-13: Global - Microfluidics Market for Drug Delivery (Billion US$), 2017-2022
  • Figure 6-14: Global - Microfluidics Market for Other Applications (Billion US$), 2017-2022
  • Figure 6-15: Global - Microfluidics Market by Geography (%), 2017
  • Figure 6-16: North America - Microfluidics Market (Billion US$), 2017-2022
  • Figure 6-17: Europe - Microfluidics Market (Billion US$), 2017-2022
  • Figure 6-18: Asia Pacific - Microfluidics Market (Billion US$), 2017-2022
  • Figure 6-19: RoW - Microfluidics Market (Billion US$), 2017-2022
  • Figure 9-1: Fluidigm Corporation - Revenue Breakup by Business Segment (%), 2017
  • Figure 9-2: Fluidigm Corporation - Revenue Breakup by Geography (%), 2017
  • Figure 9-3: F. Hoffmann-La Roche Ltd. - Revenue Breakup by Business Segment (%), 2017
  • Figure 9-4: F. Hoffmann-La Roche Ltd. - Revenue Breakup by Geography (%), 2017
  • Figure 9-5: Bio-Rad Laboratories, Inc. - Revenue Breakup by Business Segment (%), 2017
  • Figure 9-6: Bio-Rad Laboratories, Inc. - Revenue Breakup by Geography (%), 2017
  • Figure 9-7: Thermo Fisher Scientific Inc. - Revenue Breakup by Segments (%), 2017
  • Figure 9-8: Thermo Fisher Scientific Inc. - Revenue Breakup by Geography (%), 2017
  • Figure 9-9: Agilent Technologies, Inc. - Revenue Breakup by Segments (%), 2017
  • Figure 9-10: Agilent Technologies, Inc. - Revenue Breakup by Geography (%), 2017
  • Figure 9-11: Perkin Elmer, Inc. - Revenue Breakup by Business Segments (%), 2017
  • Figure 9-12: Perkin Elmer, Inc. - Revenue Breakup by Geography (%), 2017
  • Figure 9-13: Illumina, Inc. - Net Sales Break up by Business Segments (%), 2017
  • Figure 9-14: Illumina, Inc. - Net Sales Break up by Geography (%), 2017
  • Figure 9-15: Shimadzu Corporation - Net Sales Break up by Business Segments (%), 2017
  • Figure 9-16: Shimadzu Corporation - Net Sales Break up by Geography (%), 2017
  • Figure 9-17: Danaher Corporation - Revenue by Segment (%), 2017
  • Figure 9-18: Danaher Corporation - Revenue by Geography (%), 2017
  • Figure 9-19: Abbott - Revenue by Segment (%), 2017
  • Figure 9-20: Abbott - Revenue by Geography (%), 2017

List of Tables:

  • Table 5-1: Cost Involved in Microfluidics Chips
  • Table 6-1: Global - Cancer Incidences (Million), 2015 & 2025
  • Table 6-2: North America - Cancer Incidences (Million), 2015 & 2025
  • Table 6-3: Europe - Cancer Incidences (Million), 2015 & 2025
  • Table 6-4: Asia Pacific - Cancer Incidences (Million), 2015 & 2025
  • Table 6-5: Rest of the World - Cancer Incidences (Million), 2015 & 2025
  • Table 8-1: List of Grants Announced for Microfluidics Research (2014-2016)
  • Table 9-1: Fluidigm Corporation - Company Financials (Billion US$), 2015-2017
  • Table 9-2: F. Hoffmann-La Roche Ltd. - Company Financials (Billion US$), 2015-2017
  • Table 9-3: Bio-Rad Laboratories, Inc. - Company Financials (Billion US$), 2015-2017
  • Table 9-4: Thermo Fisher Scientific, Inc. - Key Financials (Million US$), 2015-2017
  • Table 9-5: Agilent Technologies, Inc. - Key Financials (Million US$), 2015-2017
  • Table 9-6: Perkin Elmer, Inc. - Company Financials (Million US$), 2015-2017
  • Table 9-7: Illumina, Inc. - Net Sales (Million US$), 2015-2017
  • Table 9-8: Shimadzu Corporation - Net Sales (Million US$), 2015-2017
  • Table 9-9: Danaher Corporation - Net Sales (Million US$), 2015-2017
  • Table 9-10: Abbott - Net Sales (Million US$), 2015-2017